Myrthe K. S. Hol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Myrthe K. S. Hol has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Cor W. R. J. Cremers
Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands
7 shared publicationsAd F. M. Snik
Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands
6 shared publicationsAd F.M. Snik
3 shared publicationsCor W.R.J. Cremers
3 shared publicationsEmmanuel A. M. Mylanus
Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
3 shared publicationsCatharina A. J. Dun
Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands
2 shared publications
Latest Publications
- 1 November 2013
- Published by Wolters Kluwer Health in Ear & Hearing
- Vol. 34 (6) , 806-808
Bilateral Bone Conduction Devices
Objectives: The aim of the study was to investigate whether children with bilateral conductive hearing loss benefit from their second device (i.e., the bilateral bone conduction device [BCD]). Design: Speech recognition in noise was assessed in 10 children fitted with bilateral BCDs during childhood. Speech recognition was measured in 2 conditions with both BCDs active. Spatial resolution was tested with the Minimum Audible Angle test in the bilateral and monaural listening conditions. Results: Children demonstrated an improvement in speech recognition when speech was presented from the front and noise was presented from the right-hand side as compared with both speech and noise being presented from the front. The minimum audible angle decreased from 57° in the best monaural condition to 13° in the bilateral condition. Conclusions: The audiological outcomes demonstrate the advantage of bilateral BCD fitting in children with bilateral conductive hearing loss.
- 1 November 2013
- Published by Wolters Kluwer Health in Ear & Hearing
- Vol. 34 (6) , 806-808
Bilateral Bone Conduction Devices
Objectives: The aim of the study was to investigate whether children with bilateral conductive hearing loss benefit from their second device (i.e., the bilateral bone conduction device [BCD]). Design: Speech recognition in noise was assessed in 10 children fitted with bilateral BCDs during childhood. Speech recognition was measured in 2 conditions with both BCDs active. Spatial resolution was tested with the Minimum Audible Angle test in the bilateral and monaural listening conditions. Results: Children demonstrated an improvement in speech recognition when speech was presented from the front and noise was presented from the right-hand side as compared with both speech and noise being presented from the front. The minimum audible angle decreased from 57° in the best monaural condition to 13° in the bilateral condition. Conclusions: The audiological outcomes demonstrate the advantage of bilateral BCD fitting in children with bilateral conductive hearing loss.
- 1 August 2013
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 34 (6) , 1071-1075
Comparison Between a New Implantable Transcutaneous Bone Conductor and Percutaneous Bone-Conduction Hearing Implant
Despite good results on osseointegration and limited skin reactions with percutaneous bone conductors, there remains room for improvement. Especially in children, adverse events with percutaneous bone conductors might occur more frequently. Transcutaneous bone conductors, if powerful enough, can provide a solution that minimizes adverse events and implant loss. This study compares a new transcutaneous bone conduction hearing aid, the Sophono Alpha 1 (Sophono), with the percutaneous BAHA system (BAHA). In our tertiary referral center, 12 patients (age 5-12 yr) with congenital unilateral conductive hearing loss were enrolled in the study as follows: 6 patients with the Sophono and 6 with the BAHA. Both clinical results and audiologic data were gathered. For an objective audiologic comparison between both systems, we used a skull simulator. The skin reactions were comparable between both groups, in 1 implant was lost 1 month after second phase surgery (BAHA). The users received audiologic benefits from both systems. The BAHA-based outcome was slightly better compared with Sophono-based results in sound field thresholds, speech recognition threshold, and speech comprehension at 65 dB. The skull simulator demonstrated that the BAHA device has an output that is 10 to 15 dB higher compared with the Sophono device. The Sophono offers appealing clinical benefits of transcutaneous bone conduction hearing; however, the audiologic challenges of transcutaneous application remain, as the Sophono does not exceed percutaneous application regarding audiologic output.
- 1 August 2013
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 34 (6) , 1071-1075
Comparison Between a New Implantable Transcutaneous Bone Conductor and Percutaneous Bone-Conduction Hearing Implant
Despite good results on osseointegration and limited skin reactions with percutaneous bone conductors, there remains room for improvement. Especially in children, adverse events with percutaneous bone conductors might occur more frequently. Transcutaneous bone conductors, if powerful enough, can provide a solution that minimizes adverse events and implant loss. This study compares a new transcutaneous bone conduction hearing aid, the Sophono Alpha 1 (Sophono), with the percutaneous BAHA system (BAHA). In our tertiary referral center, 12 patients (age 5-12 yr) with congenital unilateral conductive hearing loss were enrolled in the study as follows: 6 patients with the Sophono and 6 with the BAHA. Both clinical results and audiologic data were gathered. For an objective audiologic comparison between both systems, we used a skull simulator. The skin reactions were comparable between both groups, in 1 implant was lost 1 month after second phase surgery (BAHA). The users received audiologic benefits from both systems. The BAHA-based outcome was slightly better compared with Sophono-based results in sound field thresholds, speech recognition threshold, and speech comprehension at 65 dB. The skull simulator demonstrated that the BAHA device has an output that is 10 to 15 dB higher compared with the Sophono device. The Sophono offers appealing clinical benefits of transcutaneous bone conduction hearing; however, the audiologic challenges of transcutaneous application remain, as the Sophono does not exceed percutaneous application regarding audiologic output.
- 1 January 2013
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 34 (1) , 104-110
Bone-Anchored Hearing Implant Loading at 3 Weeks
Objective To clinically evaluate the performance of a titanium percutaneous bone-anchored hearing implant (BAHI) using a 3-week healing period. Short-term implant survival, stability changes, and skin reactions are evaluated from the initial implantation to 6 months postimplantation. Methods Thirty patients eligible for a BAHI were included in an open, prospective clinical investigation. Implant stability quotient (ISQ) values were recorded using resonance frequency analysis (RFA) at the time of implantation and at 10 days; at 3, 6, and 12 weeks; and at 6 months after placement of the implant. Sound processor fitting was performed 3 weeks after implantation. Skin reactions were evaluated according to the Holgers classification. Results One implant was lost 3 days after implantation because of poor bone quality. No implant loss occurred in the remaining 29 patients (96.7%). The mean ISQ value at the time of implantation was 67.1 (range, 44–71). Compared with baseline, there was a significant dip of -2.2 ISQ units at 10 days (mean, 65.7; p = 0.0093). There was a positive change in mean ISQ compared with baseline over the subsequent visits. No reduction in mean ISQ values was observed after implant loading. Skin reactions were observed incidentally (mean over all visits, 9.7%) and were generally mild (Holgers Grade 1; mean 9.0%). An adverse skin reaction (Holgers Grade 2) was observed only once (mean, 0.7%). Conclusion The current study suggests that loading the implant and 6-mm abutment with the sound processor at 3 weeks is safe. The stability of the implant as measured by ISQ values had reached its baseline value within 3 weeks after implantation. The degree of stability was not affected by implant loading. Only mild skin reactions were observed incidentally. This study supports the use of early loading at 3 weeks as current practice in healthy adults with good bone quality; thus, these adults can benefit from the rehabilitation of their hearing at an earlier stage.
- 1 January 2013
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 34 (1) , 104-110
Bone-Anchored Hearing Implant Loading at 3 Weeks
Objective To clinically evaluate the performance of a titanium percutaneous bone-anchored hearing implant (BAHI) using a 3-week healing period. Short-term implant survival, stability changes, and skin reactions are evaluated from the initial implantation to 6 months postimplantation. Methods Thirty patients eligible for a BAHI were included in an open, prospective clinical investigation. Implant stability quotient (ISQ) values were recorded using resonance frequency analysis (RFA) at the time of implantation and at 10 days; at 3, 6, and 12 weeks; and at 6 months after placement of the implant. Sound processor fitting was performed 3 weeks after implantation. Skin reactions were evaluated according to the Holgers classification. Results One implant was lost 3 days after implantation because of poor bone quality. No implant loss occurred in the remaining 29 patients (96.7%). The mean ISQ value at the time of implantation was 67.1 (range, 44–71). Compared with baseline, there was a significant dip of -2.2 ISQ units at 10 days (mean, 65.7; p = 0.0093). There was a positive change in mean ISQ compared with baseline over the subsequent visits. No reduction in mean ISQ values was observed after implant loading. Skin reactions were observed incidentally (mean over all visits, 9.7%) and were generally mild (Holgers Grade 1; mean 9.0%). An adverse skin reaction (Holgers Grade 2) was observed only once (mean, 0.7%). Conclusion The current study suggests that loading the implant and 6-mm abutment with the sound processor at 3 weeks is safe. The stability of the implant as measured by ISQ values had reached its baseline value within 3 weeks after implantation. The degree of stability was not affected by implant loading. Only mild skin reactions were observed incidentally. This study supports the use of early loading at 3 weeks as current practice in healthy adults with good bone quality; thus, these adults can benefit from the rehabilitation of their hearing at an earlier stage.
- Open Access
- 1 December 2012
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 138 (12) , 1129-1135
Analysis of Factors Predicting the Success of the Bone Conduction Device Headband Trial in Patients With Single-Sided Deafness
For several years, bone conduction devices (BCDs), including both the Cochlear Ltd bone-anchored hearing aid (BAHA) and, more recently, the Oticon Medical devices (Ponto) have been used as contralateral routing of sound (CROS) devices. A group of patients who benefit from this rehabilitation have unilateral sensorineural hearing loss, commonly known as single-sided deafness (SSD). Quiz Ref IDThe BCD CROS achieves significant improvement concerning some problems caused by the head shadow effect, which plays a substantial role in the hearing impairment of patients with SSD.1,2 Subjective benefit analysis by means of the Abbreviated Profile of Hearing Aid Benefit (APHAB)3 shows a significant improvement in the ease of communication, conversation in background noise, and conversations with reverberation.4-6 However, it remains difficult to predict which patients with SSD will benefit from BCD CROS treatment. All patients receiving the standard workup for BCD CROS treatment have the opportunity to try a BCD headband to help them decide whether to proceed to BCD surgery. According to studies by Andersen et al7 and Schrøder et al,8 only 20% to 25% of the patients with SSD caused by acoustic neuroma surgery opt for a percutaneous BCD CROS. Quiz Ref IDDesmet et al9 evaluated 196 patients with SSD for several factors (Fletcher index of ipsilateral and contralateral ear, bone conduction threshold [0.5, 1, and 2 kHz], etiology, age, and duration of deafness) to determine their influence on the decision of a patient to opt for a BCD or not. Eighty-seven patients (44%) opted for a BCD, but no statistically significant factors were found. Kompis et al10 also searched for predicting factors such as age, sex, transcranial attenuation, and duration of deafness in 46 patients with SSD. The decision of the 29 patients who opted for a BCD (63%) was based on subjective factors.
- 1 December 2012
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 138 (12) , 1129-1135
Open AccessAnalysis of Factors Predicting the Success of the Bone Conduction Device Headband Trial in Patients With Single-Sided Deafness
For several years, bone conduction devices (BCDs), including both the Cochlear Ltd bone-anchored hearing aid (BAHA) and, more recently, the Oticon Medical devices (Ponto) have been used as contralateral routing of sound (CROS) devices. A group of patients who benefit from this rehabilitation have unilateral sensorineural hearing loss, commonly known as single-sided deafness (SSD). Quiz Ref IDThe BCD CROS achieves significant improvement concerning some problems caused by the head shadow effect, which plays a substantial role in the hearing impairment of patients with SSD.1,2 Subjective benefit analysis by means of the Abbreviated Profile of Hearing Aid Benefit (APHAB)3 shows a significant improvement in the ease of communication, conversation in background noise, and conversations with reverberation.4-6 However, it remains difficult to predict which patients with SSD will benefit from BCD CROS treatment. All patients receiving the standard workup for BCD CROS treatment have the opportunity to try a BCD headband to help them decide whether to proceed to BCD surgery. According to studies by Andersen et al7 and Schrøder et al,8 only 20% to 25% of the patients with SSD caused by acoustic neuroma surgery opt for a percutaneous BCD CROS. Quiz Ref IDDesmet et al9 evaluated 196 patients with SSD for several factors (Fletcher index of ipsilateral and contralateral ear, bone conduction threshold [0.5, 1, and 2 kHz], etiology, age, and duration of deafness) to determine their influence on the decision of a patient to opt for a BCD or not. Eighty-seven patients (44%) opted for a BCD, but no statistically significant factors were found. Kompis et al10 also searched for predicting factors such as age, sex, transcranial attenuation, and duration of deafness in 46 patients with SSD. The decision of the 29 patients who opted for a BCD (63%) was based on subjective factors.
- 1 December 2010
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 31 (9) , 1412-1416
Tympanoplasty in Chronic Otitis Media Patients With an Intact, but Severely Retracted Malleus
Objective: To analyze the outcome of patients with chronic otitis media (COM) with an intact, but markedly medialized ossicular chain, treated by removing the malleus head and interposing an autologous incus and then an underlay myringoplasty. Study Design: Retrospective clinical study. Setting: Tertiary referral center. Patients: The search criteria within the prospective surgical database was COM with a central perforation (without cholesteatoma) with a markedly medialized malleus handle (the umbo adherent to the promontory) with an intact ossicular chain (study, n = 15) or an incus necrosis at the lenticular process (incus, n = 23). Only primary surgeries performed at our otorhinolaryngology department were included. Intervention: All patients underwent the same surgical procedure consisting of an autologous incus interposition and underlay myringoplasty with temporalis fascia. Main Outcome Measure: The patients' audiological and follow-up data were retrieved from the database. The postoperative audiogram (0.5-3 kHz) with the longest follow-up was used. Results: The preoperative air-conduction thresholds were less impaired in the study group than in the incus group. After their surgery, all, except 3 patients, improved their hearing, and 97% had an intact tympanic membrane at a mean follow-up of 2 years. The air-bone gap was closed within 20 dB in 80% (study) and in 87% (incus), in one third of all patients even within 10 dB. Although the largest improvement was seen in the lower frequencies, closure of the air-bone gap at 4 kHz was difficult to achieve. Conclusion: Patients presenting with COM, a (central) perforation, a medially rotated malleus and intact ossicular chain are a treatment challenge. Lateralizing the malleus handle may require disconnection of the ossicular chain and an autologous incus interposition to bring back the reconstructed tympanic membrane in its original position and improve the hearing.
- 1 December 2010
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 31 (9) , 1412-1416
Tympanoplasty in Chronic Otitis Media Patients With an Intact, but Severely Retracted Malleus
Objective: To analyze the outcome of patients with chronic otitis media (COM) with an intact, but markedly medialized ossicular chain, treated by removing the malleus head and interposing an autologous incus and then an underlay myringoplasty. Study Design: Retrospective clinical study. Setting: Tertiary referral center. Patients: The search criteria within the prospective surgical database was COM with a central perforation (without cholesteatoma) with a markedly medialized malleus handle (the umbo adherent to the promontory) with an intact ossicular chain (study, n = 15) or an incus necrosis at the lenticular process (incus, n = 23). Only primary surgeries performed at our otorhinolaryngology department were included. Intervention: All patients underwent the same surgical procedure consisting of an autologous incus interposition and underlay myringoplasty with temporalis fascia. Main Outcome Measure: The patients' audiological and follow-up data were retrieved from the database. The postoperative audiogram (0.5-3 kHz) with the longest follow-up was used. Results: The preoperative air-conduction thresholds were less impaired in the study group than in the incus group. After their surgery, all, except 3 patients, improved their hearing, and 97% had an intact tympanic membrane at a mean follow-up of 2 years. The air-bone gap was closed within 20 dB in 80% (study) and in 87% (incus), in one third of all patients even within 10 dB. Although the largest improvement was seen in the lower frequencies, closure of the air-bone gap at 4 kHz was difficult to achieve. Conclusion: Patients presenting with COM, a (central) perforation, a medially rotated malleus and intact ossicular chain are a treatment challenge. Lateralizing the malleus handle may require disconnection of the ossicular chain and an autologous incus interposition to bring back the reconstructed tympanic membrane in its original position and improve the hearing.
- Open Access
- 11 November 2009
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 267 (6) , 889-896
Pilot study on the effectiveness of the conventional CROS, the transcranial CROS and the BAHA transcranial CROS in adults with unilateral inner ear deafness
The objective of the present pilot study is to evaluate the effectiveness of three conventional contralateral routing of sound (CROS) hearing aids in adults with unilateral inner ear deafness. The study included tertiary referral center. Ten patients with unilateral inner ear deafness and normal hearing in the contralateral ear were selected to evaluate three different methods of amplification: the CROS hearing aid, the completely in the canal hearing aid and the bone-anchored hearing aid CROS (BAHA). Each of the three hearing aids was tried in a random order for a period of 8 weeks. Audiometric performance, including speech-in-noise, directional hearing and subjective benefit were measured after each trial period, using the APHAB, SSQ and single-sided deafness questionnaire. Sound localization performance was essentially at chance level in all four conditions. Mixed results were seen on the other patient outcome measures that alternated in favor of one of the three CROS devices. After the trial, three patients chose to be fitted with the BAHA CROS and one with the conventional CROS. In conclusion, most of the patients experienced some degree of benefit with each of the three hearing aids. Preference for one of the three hearing aids was independent of the order in which they were tried. It would be worthwhile to formulate selection criteria; still, we recommend that all patients with unilateral inner ear deafness should be offered a trial with at least the BAHA CROS.
- 11 November 2009
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 267 (6) , 889-896
Open AccessPilot study on the effectiveness of the conventional CROS, the transcranial CROS and the BAHA transcranial CROS in adults with unilateral inner ear deafness
The objective of the present pilot study is to evaluate the effectiveness of three conventional contralateral routing of sound (CROS) hearing aids in adults with unilateral inner ear deafness. The study included tertiary referral center. Ten patients with unilateral inner ear deafness and normal hearing in the contralateral ear were selected to evaluate three different methods of amplification: the CROS hearing aid, the completely in the canal hearing aid and the bone-anchored hearing aid CROS (BAHA). Each of the three hearing aids was tried in a random order for a period of 8 weeks. Audiometric performance, including speech-in-noise, directional hearing and subjective benefit were measured after each trial period, using the APHAB, SSQ and single-sided deafness questionnaire. Sound localization performance was essentially at chance level in all four conditions. Mixed results were seen on the other patient outcome measures that alternated in favor of one of the three CROS devices. After the trial, three patients chose to be fitted with the BAHA CROS and one with the conventional CROS. In conclusion, most of the patients experienced some degree of benefit with each of the three hearing aids. Preference for one of the three hearing aids was independent of the order in which they were tried. It would be worthwhile to formulate selection criteria; still, we recommend that all patients with unilateral inner ear deafness should be offered a trial with at least the BAHA CROS.
- 1 September 2005
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 26 (5) , 999-1006
Bone-Anchored Hearing Aids in Unilateral Inner Ear Deafness: An Evaluation of Audiometric and Patient Outcome Measurements
To evaluate the benefit of a bone-anchored hearing aid contralateral routing of sound hearing aid (BAHA CROS hearing aid) in 29 patients with unilateral inner ear deafness. Prospective clinical follow-up study. Tertiary referral center. Thirty patients were recruited. There were 19 patients with a history of acoustic neuroma surgery and 11 patients with unilateral inner ear deafness due to other causes; 1 patient was excluded. The first 21 patients had also participated in a previous evaluation. Audiometric measurements were taken before intervention, when fitted with a conventional CROS, and after BAHA implementation. Patients' subjective benefit was quantified with four different hearing aid-specific instruments: the Abbreviated Profile of Hearing Aid Benefit, the Glasgow Hearing Aid Benefit Profile, the International Outcome Inventory for Hearing Aids, and the Single-Sided Deafness questionnaire. The same instruments were used at a mean long-term follow-up of 1 year after BAHA implantation. Sound localization in an audiologic test setting was no different from chance level. The main effect of the BAHA CROS that was found was the “lift the head shadow” effect in the speech-in-noise measurements. All instruments also showed positive results in favor of the BAHA CROS at long-term follow-up. The poor sound-localization results in an audiologic test setting illustrated the inability of patients with unilateral inner ear deafness to localize sounds. The speech-in-noise measurements demonstrated the efficacy of the BAHA CROS to lift the head shadow. Patients were still satisfied at 1-year follow-up, according to the four instruments.
- 1 September 2005
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 26 (5) , 999-1006
Bone-Anchored Hearing Aids in Unilateral Inner Ear Deafness: An Evaluation of Audiometric and Patient Outcome Measurements
To evaluate the benefit of a bone-anchored hearing aid contralateral routing of sound hearing aid (BAHA CROS hearing aid) in 29 patients with unilateral inner ear deafness. Prospective clinical follow-up study. Tertiary referral center. Thirty patients were recruited. There were 19 patients with a history of acoustic neuroma surgery and 11 patients with unilateral inner ear deafness due to other causes; 1 patient was excluded. The first 21 patients had also participated in a previous evaluation. Audiometric measurements were taken before intervention, when fitted with a conventional CROS, and after BAHA implementation. Patients' subjective benefit was quantified with four different hearing aid-specific instruments: the Abbreviated Profile of Hearing Aid Benefit, the Glasgow Hearing Aid Benefit Profile, the International Outcome Inventory for Hearing Aids, and the Single-Sided Deafness questionnaire. The same instruments were used at a mean long-term follow-up of 1 year after BAHA implantation. Sound localization in an audiologic test setting was no different from chance level. The main effect of the BAHA CROS that was found was the “lift the head shadow” effect in the speech-in-noise measurements. All instruments also showed positive results in favor of the BAHA CROS at long-term follow-up. The poor sound-localization results in an audiologic test setting illustrated the inability of patients with unilateral inner ear deafness to localize sounds. The speech-in-noise measurements demonstrated the efficacy of the BAHA CROS to lift the head shadow. Patients were still satisfied at 1-year follow-up, according to the four instruments.
- 1 July 2005
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 69 (7) , 973-980
The BAHA Softband
- 1 July 2005
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 69 (7) , 973-980
The BAHA Softband
- 6 May 2005
- Published by S. Karger AG in Audiology and Neurotology
- Vol. 10 (3) , 159-168
Does the Bone-Anchored Hearing Aid Have a Complementary Effect on Audiological and Subjective Outcomes in Patients with Unilateral Conductive Hearing Loss?
Objectives: To study the effect of a bone-anchored hearing aid (BAHA) in patients with unilateral conductive hearing loss. Study Design: Prospective evaluation on 18 subjects. Methods:Aided and unaided binaural hearing was assessed in the sound field using a sound localization test and a speech recognition in noise test with spatially separated sound and noise sources. The patients also filled out a disability-specific questionnaire. Patients: 13 out of the 18 subjects had normal hearing on one side and acquired conductive hearing loss in the other ear. The remaining 5 patients had a unilateral air-bone gap and mild symmetrical sensorineural hearing loss. Results:Sound localization with the BAHA improved significantly. Speech recognition in noise with spatially separated speech and noise sources also improved with the BAHA. Fitting a BAHA to patients with unilateral conductive hearing loss had a complementary effect on hearing. Questionnaire results showed that the BAHA was of obvious benefit in daily life. Conclusions: The BAHA proved to be a beneficial means to optimize binaural hearing in patients with severe (40–60 dB) unilateral conductive hearing loss according to audiometric data and patient outcome measures.
- 6 May 2005
- Published by S. Karger AG in Audiology and Neurotology
- Vol. 10 (3) , 159-168
Does the Bone-Anchored Hearing Aid Have a Complementary Effect on Audiological and Subjective Outcomes in Patients with Unilateral Conductive Hearing Loss?
Objectives: To study the effect of a bone-anchored hearing aid (BAHA) in patients with unilateral conductive hearing loss. Study Design: Prospective evaluation on 18 subjects. Methods:Aided and unaided binaural hearing was assessed in the sound field using a sound localization test and a speech recognition in noise test with spatially separated sound and noise sources. The patients also filled out a disability-specific questionnaire. Patients: 13 out of the 18 subjects had normal hearing on one side and acquired conductive hearing loss in the other ear. The remaining 5 patients had a unilateral air-bone gap and mild symmetrical sensorineural hearing loss. Results:Sound localization with the BAHA improved significantly. Speech recognition in noise with spatially separated speech and noise sources also improved with the BAHA. Fitting a BAHA to patients with unilateral conductive hearing loss had a complementary effect on hearing. Questionnaire results showed that the BAHA was of obvious benefit in daily life. Conclusions: The BAHA proved to be a beneficial means to optimize binaural hearing in patients with severe (40–60 dB) unilateral conductive hearing loss according to audiometric data and patient outcome measures.
- 1 April 2005
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 131 (4) , 321-325
Long-term Results of Bone-Anchored Hearing Aid Recipients Who Had Previously Used Air-Conduction Hearing Aids
Research from JAMA Otolaryngology–Head & Neck Surgery — Long-term Results of Bone-Anchored Hearing Aid Recipients Who Had Previously Used Air-Conduction Hearing Aids
- 1 April 2005
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 131 (4) , 321-325
Long-term Results of Bone-Anchored Hearing Aid Recipients Who Had Previously Used Air-Conduction Hearing Aids
Research from JAMA Otolaryngology–Head & Neck Surgery — Long-term Results of Bone-Anchored Hearing Aid Recipients Who Had Previously Used Air-Conduction Hearing Aids